Uracil C-13
- Generic Name
- Uracil C-13
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C4H4N2O2
- CAS Number
- 35803-45-3
- Unique Ingredient Identifier
- OZF8J4VAIK
- Background
Uracil C-13 is under investigation in clinical trial NCT01677338 (Phase 2 Study to Evaluate the Preliminary Performance of the C13-URA Breath Test Kit in Dyspeptic Subjects).
- Associated Conditions
- -
- Associated Therapies
- -
Phase 2 Study to Evaluate the Preliminary Performance of the C13-URA Breath Test Kit in Dyspeptic Subjects
- First Posted Date
- 2012-09-03
- Last Posted Date
- 2019-04-08
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT01677338
- Locations
- 🇺🇸
Compass Research, Orlando, Florida, United States
🇺🇸Dartmouth-Hitchcock Medical Center, Gastroenterology and Hepatology, Lebanon, New Hampshire, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath